Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 2-Biden says he plans to back WTO IP waiver for COVID-19 vaccines

Wed, 05th May 2021 20:18

(Adds USTR statement, background)

WASHINGTON, May 5 (Reuters) - President Joe Biden on
Wednesday threw his support behind a proposed World Trade
Organization waiver of intellectual property rights for COVID-19
vaccines, bowing to mounting pressure from Democratic lawmakers
and more than 100 other countries.

Biden, who had backed a waiver during the 2020 presidential
campaign, voiced his support after a speech at the White House.

"Yes, I'm going to talk about that later today, yes," Biden
told reporters in reply to a question about whether he intended
to back the waiver.

Biden's chief trade negotiator, U.S. Trade Representative
Katherine Tai, issued a statement shortly after Biden spoke,
announcing the Biden administration's support for the proposed
measure, which would temporarily waive certain IP rights to help
countries respond to the COVID-19 pandemic.

“This is a global health crisis, and the extraordinary
circumstances of the COVID-19 pandemic call for extraordinary
measures," Tai said in a statement.

"The Administration believes strongly in intellectual
property protections, but in service of ending this pandemic,
supports the waiver of those protections for COVID-19 vaccines."

Tai said the United States would participate in text-based
negotiations at the WTO to ensure the waiver could happen, but
cautioned those negotiations would take time.

WTO decisions require a consensus of all members.

The United States and several other countries had previously
blocked negotiations at the WTO about the waiver proposal led by
India and South Africa aimed at helping developing countries to
produce COVID-19 vaccines using the IP of pharmaceutical
companies.
(Reporting by Andrea Shalal, Steve Holland and Jeff Mason;
Editing by Peter Cooney)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.